Bajaj Consumer Care (BAJAJCON) Q1 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 24/25 earnings summary
1 Feb, 2026Executive summary
Q1 FY25 standalone sales were INR 236.9 crores, down 8.8% year-on-year but up 2.9% sequentially, impacted by a high base and a one-time wholesale channel correction.
The company implemented a planned hygiene correction in the wholesale channel, rationalizing discounts and broadening the wholesaler base by 13%, expected to improve future performance.
Retail and rural channels remained steady, with retail loyalty programs reaching 12,000 outlets and ongoing focus on expanding retail presence.
Project Aarohan, a distribution revamp, is underway to enhance reach in high-potential towns and villages, aiming for a 1.4x increase in urban retail outlets and 1.1-1.2x in rural villages.
Auditors issued unmodified (clean) limited review reports for both standalone and consolidated results.
Financial highlights
Standalone revenue from operations for Q1 FY25 was ₹24,117.84 lakh, down from ₹26,418.07 lakh in Q1 FY24 and up from ₹23,590.71 lakh in Q4 FY24.
Gross margin for Q1 FY25 was 55.2%, expanding by over 50 basis points both sequentially and year-on-year.
Standalone EBITDA stood at INR 38.4 crores, with an EBITDA margin of 16.2% of sales.
Standalone PAT for Q1 FY25 was ₹3,798.16 lakh, compared to ₹4,541.13 lakh in Q1 FY24 and ₹3,730.75 lakh in Q4 FY24.
Non-ADHO portfolio contributed 18% of total revenue in Q1 FY25, growing 17% year-on-year.
Outlook and guidance
Targeting mid- to high single-digit growth for FY25, with Q2 expected to be stronger due to the correction and Project Aarohan.
Long-term goal is a sustained double-digit CAGR, driven by new products and international expansion.
EBITDA margin guidance remains at 16%-18%, with potential for improvement as scale builds.
Urban demand expected to remain stable; rural demand to improve with higher government spending.
Raw material prices projected to stay stable.
Latest events from Bajaj Consumer Care
- Q3 FY26 delivered 32.7% revenue growth and 83.2% PAT increase, led by strong domestic gains.BAJAJCON
Q3 25/2621 Jan 2026 - Q2 FY25 saw flat sales, margin pressure, strong international growth, and a major share buyback.BAJAJCON
Q2 24/2515 Jan 2026 - Q4 margins rose, but FY25 profit and revenue fell; expansion and integration continue.BAJAJCON
Q4 24/2524 Dec 2025 - Revenue and profit declined, but portfolio expansion and international growth remain strong.BAJAJCON
Q3 24/2523 Dec 2025 - Revenue and margins rose YoY, led by ADHO and coconut oil, with buyback and acquisition completed.BAJAJCON
Q1 25/2626 Nov 2025 - Strong revenue and profit growth, margin gains, GST reforms, and share buyback marked Q2 FY26.BAJAJCON
Q2 25/2611 Nov 2025